P-526 Phase I/II study of GTI-2040 plus docetaxel as...

Lung Cancer 2005 / 7 Vol. 49

P-526 Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)

Leighl, N., Laurie, S., Knox, J., Ellis, P., Shepherd, F., Burkes, R., Pond, G., Zwiebel, J., Moore, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81019-0
Date:
July, 2005
File:
PDF, 286 KB
english, 2005
Conversion to is in progress
Conversion to is failed